3 research outputs found

    Activity Concentrations of Sr-90 and Cs-137 in Seawater and Sediment in the Gulf of Tonkin, Vietnam

    No full text
    In this study, we measured the activity concentrations of Cs-137 and Sr-90 in surface seawater and surface sediments at the Tra Co, Bach Long Vi, and Ky Anh locations in the Gulf of Tonkin, Vietnam, from December 2018 to October 2019. The average activity at the selected locations was 1.22, 1.43, and 1.33 Bq/m3 for Cs-137 and 0.88, 1.17, and 1.09 Bq/m3 for Sr-90 in surface seawater samples and 0.74, 1.01, and 0.81 Bq/kg dry for Cs-137 and 0.49, 0.49, and 0.43 Bq/kg dry for Sr-90 in sediment samples. The ratio of the average activity concentration (Cs-137/Sr-90) in the surface seawater was 1.42, 1.22, and 1.22 at the Tra Co, Bach Long Vi, and Ky Anh locations, respectively. These are somewhat low compared to the global ratios (1.6 and 1.8). Meanwhile, Cs-137/Sr-90 ratios in the sediment samples at the selected locations were 1.51, 2.06, and 1.88, respectively, which is equal to or greater than the corresponding value for global sedimentation according to the United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR). Correlations between Sr-90, Cs-137, and organic carbon content were detected in this study. The results showed that Cs-137 has a high correlation with the organic carbon content in sediment, while Sr-90 has a low correlation

    An observational study of breakthrough SARS-CoV-2 Delta variant infections among vaccinated healthcare workers in Vietnam

    No full text
    Background Data on breakthrough SARS-CoV-2 Delta variant infections in vaccinated individuals are limited. Methods We studied breakthrough infections among Oxford-AstraZeneca vaccinated healthcare workers in an infectious diseases hospital in Vietnam. We collected demographic and clinical data alongside serial PCR testing, measurement of SARS-CoV-2 antibodies, and viral whole-genome sequencing. Findings Between 11th–25th June 2021 (7-8 weeks after the second dose), 69 staff tested positive for SARS-CoV-2. 62 participated in the study. Most were asymptomatic or mildly symptomatic and all recovered. Twenty-two complete-genome sequences were obtained; all were Delta variant and were phylogenetically distinct from contemporary viruses obtained from the community or from hospital patients admitted prior to the outbreak. Viral loads inferred from Ct values were 251 times higher than in cases infected with the original strain in March/April 2020. Median time from diagnosis to negative PCR was 21 days (range 8–33). Neutralizing antibodies (expressed as percentage of inhibition) measured after the second vaccine dose, or at diagnosis, were lower in cases than in uninfected, fully vaccinated controls (median (IQR): 69.4 (50.7-89.1) vs. 91.3 (79.6-94.9), p=0.005 and 59.4 (32.5-73.1) vs. 91.1 (77.3-94.2), p=0.043). There was no correlation between vaccine-induced neutralizing antibody levels and peak viral loads or the development of symptoms. Interpretation Breakthrough Delta variant infections following Oxford-AstraZeneca vaccination may cause asymptomatic or mild disease, but are associated with high viral loads, prolonged PCR positivity and low levels of vaccine-induced neutralizing antibodies. Epidemiological and sequence data suggested ongoing transmission had occurred between fully vaccinated individuals
    corecore